Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels;Impacto de la vacuna neumocócica conjugada heptavalente en una población con valores bajos-intermedios de vacunación

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue 5, 2009, Pages 275-277

  Salleras, Lluís ^a,b   Domínguez, Ngela ^a,b,c   Ciruela, Pilar ^c   Izquierdo, Conchita ^b,c   Borrs, Eva ^b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Plan Director de las Enfermedades Reumáticas y del Aparato Locomotor   (Spain)

Author keywords

7 valent pneumococcal conjugate vaccine; Children<2 years old; Impact vaccination; Invasive pneumococcal disease; Pneumococcus; Vaccination coverage

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; CHILD; DRUG EFFICACY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIA; VACCINATION;

HUMANS; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINATION; VACCINES, CONJUGATE;

EID: 67349201693     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2008.09.010     Document Type: Article

References (10)

1. S. Black, H. Shinefield, B. Fireman, E. Lewis, and P. Ray Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Pediatr Infect Dis J 19 2000 187 195
2. L. Salleras, A. Fenoll, A. Domínguez, E. Navas, and J. Casal Cobertura de serotipos de la vacuna antineumocócica conjugada heptavalente. Cataluña, 1997-2002 Vacunas 4 2003 73 79
3. E. Borras, A. Domínguez, J. Batalla, N. Torner, N. Cardenosa, and M. Nebot Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain) Vaccine 25 2007 3240 3243
4. E. Bernaola, F. Giménez, M. Baca, F. De Juan, J. Díez Domingo, and M. Garcés Calendario de vacunación de la Asociación Española de Pediatría: recomendaciones 2006 An Pediatr (Barc) 64 2006 74 77
5. G.E. Schutze, N.C. Tucker, and E.O. Mason Jr Impact of the conjugate pneumococcal vaccine in Arkansas Pediatr Infect Dis J 23 2004 1125 1129
6. R.I. Haddy, K. Perry, C.E. Chacko, W.B. Helton, M.G. Bowling, and S.W. Looney Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine Pediatr Infect Dis J 24 2005 320 323
7. K. Hsu, S. Pelton, S. Karumuri, D. Heisey-Grove, and J. Klein Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine Pediatr Infect Dis J 24 2005 17 23
8. J. Aristegui, E. Bernaola, I. Pocheville, C. García, L. Arranz, and G. Duran Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine Eur J Clin Microbiol Infect Dis 26 2007 303 310
9. A. Barricarte, A. Gil, L. Torroba, J. Castilla, A. Petit, and I. Polo Enfermedad neumocócica invasiva en la población menor de 5 años de edad de Navarra (2000-2005): impacto de la vacuna conjugada Med Clin (Barc) 129 2007 41 45
10. J. Benito-Fernández, S. Mintegi-Raso, I. Pocheville-Gurutzeta, J. Sánchez-Etxaniz, B. Azkunaga-Santisteban, and S. Capapé-Zache Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain Pediatr Infect Dis J 26 2007 667 671